Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Houston

Showing results (51-60 of 156) with videos related to

Pageof 16
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 16, 2003
Multisite kinetic analysis of interactions between prototypical CYP3A4 subgroup substrates: midazolam, testosterone, and nifedipineAleksandra Galetin, Stephen E Clarke, J Brian Houston
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 30, 2006
Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearanceHayley S Brown, Michael Griffin, J Brian Houston
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 17, 2012
Evaluation of the novel in vitro systems for hepatic drug clearance and assessment of their predictive utilityJ Brian Houston, Karen Rowland-Yeo, Ugo Zanelli
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 21, 2011
Predictive utility of in vitro rifampin induction data generated in fresh and cryopreserved human hepatocytes, Fa2N-4, and HepaRG cellsIan E Templeton, J Brian Houston, Aleksandra Galetin
The Journal of Pharmacology and Experimental Therapeutics|December 2, 2004
Predictive models of CYP3A4 Heteroactivation: in vitro-in vivo scaling and pharmacophore modelingAnn-Charlotte Egnell, J Brian Houston, C Scott Boyer
The Journal of Pharmacology and Experimental Therapeutics|March 24, 2005
CYP3A4 substrate selection and substitution in the prediction of potential drug-drug interactionsAleksandra Galetin, Kiyomi Ito, David Hallifax, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 14, 2005
Prediction of time-dependent CYP3A4 drug-drug interactions: impact of enzyme degradation, parallel elimination pathways, and intestinal inhibitionAleksandra Galetin, Howard Burt, Laura Gibbons, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 7, 2010
Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability dataMichael Gertz, Anthony Harrison, J Brian Houston, et al.
Journal of Pharmaceutical Sciences|October 16, 2008
Methodology for development of a physiological model incorporating CYP3A and P-glycoprotein for the prediction of intestinal drug absorptionRaj Badhan, Jeffrey Penny, Aleksandra Galetin, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 5, 2012
Clearance-dependent underprediction of in vivo intrinsic clearance from human hepatocytes: comparison with permeabilities from artificial membrane (PAMPA) assay, in silico and caco-2 assay, for 65 drugsDavid Hallifax, Elisa Turlizzi, Ugo Zanelli, et al.
Pageof 16

Showing results (51-60 of 156) with videos related to

Sort By:
Pageof 16
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 16, 2003
Multisite kinetic analysis of interactions between prototypical CYP3A4 subgroup substrates: midazolam, testosterone, and nifedipineAleksandra Galetin, Stephen E Clarke, J Brian Houston
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 30, 2006
Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearanceHayley S Brown, Michael Griffin, J Brian Houston
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 17, 2012
Evaluation of the novel in vitro systems for hepatic drug clearance and assessment of their predictive utilityJ Brian Houston, Karen Rowland-Yeo, Ugo Zanelli
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 21, 2011
Predictive utility of in vitro rifampin induction data generated in fresh and cryopreserved human hepatocytes, Fa2N-4, and HepaRG cellsIan E Templeton, J Brian Houston, Aleksandra Galetin
The Journal of Pharmacology and Experimental Therapeutics|December 2, 2004
Predictive models of CYP3A4 Heteroactivation: in vitro-in vivo scaling and pharmacophore modelingAnn-Charlotte Egnell, J Brian Houston, C Scott Boyer
The Journal of Pharmacology and Experimental Therapeutics|March 24, 2005
CYP3A4 substrate selection and substitution in the prediction of potential drug-drug interactionsAleksandra Galetin, Kiyomi Ito, David Hallifax, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 14, 2005
Prediction of time-dependent CYP3A4 drug-drug interactions: impact of enzyme degradation, parallel elimination pathways, and intestinal inhibitionAleksandra Galetin, Howard Burt, Laura Gibbons, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 7, 2010
Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability dataMichael Gertz, Anthony Harrison, J Brian Houston, et al.
Journal of Pharmaceutical Sciences|October 16, 2008
Methodology for development of a physiological model incorporating CYP3A and P-glycoprotein for the prediction of intestinal drug absorptionRaj Badhan, Jeffrey Penny, Aleksandra Galetin, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 5, 2012
Clearance-dependent underprediction of in vivo intrinsic clearance from human hepatocytes: comparison with permeabilities from artificial membrane (PAMPA) assay, in silico and caco-2 assay, for 65 drugsDavid Hallifax, Elisa Turlizzi, Ugo Zanelli, et al.
Pageof 16